{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-000316","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2025-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.577580+00:00","generated_at":"2026-05-24T06:26:30.046062+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"NAYA Biosciences executes 1-for-12 reverse stock split to regain Nasdaq compliance","bullets":["Reverse split effective 12:01 a.m. ET on March 18, 2025; stock trades under same symbol 'NAYA'.","Post-split shares outstanding approx. 666,057; authorized shares reduced to 4,166,666.","Fractional shares rounded up to next whole share; new CUSIP number 44984F609.","Split intended to meet Nasdaq $1.00 minimum bid price requirement for continued listing.","No assurance that reverse split will enable compliance with Nasdaq listing standards."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-000316","json":"https://secwatch.observer/filing/0001641172-25-000316.json","markdown":"https://secwatch.observer/filing/0001641172-25-000316.md","text":"https://secwatch.observer/filing/0001641172-25-000316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000164117225000316/0001641172-25-000316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000164117225000316/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:26:30.046062+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"df3e2df0fae04f7324e70f1ea04ca872a7789d9c","claim":"INVO Fertility, Inc.: Amended certificate of incorporation to effect a 1-for-12 reverse stock split of common stock and adjust authorized shares from 50,000,000 to 4,166,667 (effective 2025-03-18).","evidence_excerpt":"On March 18, 2025, NAYA Biosciences, Inc. (the “Company”) filed a Certificate of Change (the “Certificate of Change”) with the Secretary of State of the State of Nevada to effectuate a 1-for-12 reverse stock split (the “Reverse Stock Split”) of the Company’s issued and outstanding and authorized shares of common stock, par value $0.0001 per share (“Common Stock”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000164117225000316/0001641172-25-000316-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-03-18"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}